Why Did CoreWeave, Inc. (CRWV) Stock Move Down -11.38% Today?
Key Takeaways
- Shares of CRWV declined approximately 11.38% in Friday's session, falling from a prior close of $97.63 to around $86.52, after the company reported Q4 2025 earnings after the bell on Thursday, February 26
- The primary catalyst was a wider-than-expected net loss of $0.56 per share on EPS expectations of −$0.49, alongside a massive capex plan calling for $30–$35 billion in infrastructure spending in 2026, more than doubling the prior year
- Q1 2026 revenue guidance of $1.9–$2.0 billion fell short of the $2.29 billion analysts had projected, adding to near-term pressure on the stock
- Despite a revenue beat for Q4 ($1.57 billion vs. estimates of $1.53–$1.55 billion) and a $66.8 billion contracted backlog, investors focused on ballooning losses and cash burn
- Full-year 2026 revenue guidance of $12–$13 billion came in roughly in line with the $12.09 billion consensus, offering little upside comfort
- Traders are closely watching margin recovery timelines, capex execution, and whether CoreWeave can convert its unprecedented backlog into profitability
Opening Summary
CoreWeave, Inc. (CRWV) is a Nasdaq-listed AI cloud infrastructure provider specializing in GPU-accelerated computing, primarily serving hyperscalers, AI-native companies, and enterprise clients with high-performance workloads. Shares fell approximately 11.38% on Friday, February 27, declining from the prior closing price of $97.63 to approximately $86.52 in early trading. The selloff followed the company's after-hours Q4 2025 earnings release, which revealed a net loss per share that exceeded analyst estimates and featured a capital expenditure projection for 2026 that more than doubled the prior year's figure, unnerving investors despite a headline revenue beat.
Earnings Miss on the Bottom Line
CoreWeave reported Q4 2025 earnings per share of −$0.56, falling short of the Wall Street consensus of −$0.49, a meaningful miss that highlighted the accelerating cost burden of rapid infrastructure expansion. The company's Q4 net loss reached $452 million, compared to a $51 million net loss in Q4 2024, driven largely by interest expenses that surged to $388 million from $149 million a year earlier. While adjusted EBITDA for the quarter came in at $898 million with a 57% margin, GAAP profitability remains elusive and deteriorating as the company races to deploy capacity ahead of customer revenue ramp.
$30 Billion Capex Shock
The single most impactful number from the earnings release was CoreWeave's 2026 capital expenditure guidance of $30–$35 billion, a figure that more than doubled the company's 2025 levels. Management explained that costs are recognized immediately when new data center capacity comes online, while revenue from those deployments ramps over subsequent months, creating a significant near-term earnings gap. This front-loaded investment model raises legitimate questions about free cash flow and dilution risk, even as management expressed confidence that the company is "virtually sold out" through 2026.
Guidance Disappointment on Q1 Revenue
CoreWeave guided Q1 2026 revenue to between $1.9 billion and $2.0 billion, notably below the $2.29 billion that analysts tracked by LSEG had anticipated. Full-year 2026 revenue guidance of $12–$13 billion was roughly in line with the $12.09 billion consensus, but offered no meaningful upside surprise to offset the earnings miss and capex escalation. Management also flagged that Q1 2026 adjusted operating income would range from $0 to $40 million, with margins expected to trough in the first quarter before recovering to low double digits by Q4 and eventually reaching a 25–30% long-term target.
The Backlog Narrative vs. Near-Term Reality
On the positive side, CoreWeave reported a contracted revenue backlog of $66.8 billion and full-year 2025 revenue of $5.1 billion, up 168% year-over-year, with Q4 revenue of $1.57 billion exceeding analyst estimates of $1.53–$1.55 billion. Management pointed to multi-year contract extensions and broadening demand from hyperscalers as evidence of structural tailwinds for AI infrastructure. However, the gap between backlog scale and near-term profitability left many investors unconvinced, as the stock's reaction demonstrated that execution risk and cash burn are the market's current primary concern.
Market Context and Trading Activity
Friday's trading volume in CRWV was elevated, consistent with heavy post-earnings activity. The broader technology sector and AI-adjacent names saw mixed action, but CRWV's decline was considerably more pronounced than sector peers, reflecting company-specific rather than macro-driven selling. From a technical standpoint, the drop pushed shares significantly below the 50-day moving average of approximately $86.16–$86.65, a key support level that, if lost on a closing basis, could invite additional technical selling pressure. The stock's 52-week range of $33.52–$187.00 illustrates just how volatile CRWV has been since its IPO.
Trending AI Robots
For traders and investors navigating fast-moving AI stocks like CRWV, Tickeron's Trending AI Robots page offers a curated selection of the platform's best-performing automated trading bots under current market conditions. Tickeron operates hundreds of AI-powered bots covering thousands of tickers, but only those demonstrating the strongest real-time performance metrics are featured in the Trending section. Bots vary by strategy (momentum, mean-reversion, pattern recognition), timeframe, and the specific symbols they trade, allowing users to match a bot's approach to their own risk tolerance and investment style. Whether you are tracking earnings-driven momentum plays or seeking more systematic entries and exits, exploring the Trending AI Robots page is a practical starting point for integrating AI-assisted trading tools into your process.
What Comes Next for CRWV
With Q1 2026 expected to be the trough quarter for margins, investors will be watching closely whether CoreWeave can execute on its infrastructure build-out and deliver a sequential improvement in adjusted operating income through the year. The company has outlined an ambitious long-term revenue trajectory, targeting annualized run-rate revenues of $17–$19 billion by end of 2026 and more than $30 billion by end of 2027. Outstanding risks include ongoing securities fraud class action litigation — with a lead plaintiff deadline of March 13, 2026 — significant insider selling over recent months, and execution uncertainty around deploying $30+ billion in capital with the expected returns. Analyst consensus remains a "Buy" with a price target of approximately $124–$125, but multiple firms have already moved to cut their targets following Friday's reaction, and further estimate revisions are likely in the days ahead. The Q1 2026 earnings report will be the next critical data point to assess whether the margin recovery narrative is on track.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
CRWV sees its Stochastic Oscillator ascends from oversold territory
On March 12, 2026, the Stochastic Oscillator for CRWV moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 9 instances where the indicator left the oversold zone. In of the 9 cases the stock moved higher in the following days. This puts the odds of a move higher at over .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on March 13, 2026. You may want to consider a long position or call options on CRWV as a result. In of 10 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CRWV advanced for three days, in of 49 cases, the price rose further within the following month. The odds of a continued upward trend are .
CRWV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for CRWV turned negative on February 27, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 5 similar instances when the indicator turned negative. In of the 5 cases the stock turned lower in the days that followed. This puts the odds of success at .
CRWV moved below its 50-day moving average on February 27, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CRWV crossed bearishly below the 50-day moving average on March 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 2 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRWV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for CRWV entered a downward trend on March 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.788) is normal, around the industry mean (39.080). P/E Ratio (0.000) is within average values for comparable stocks, (141.890). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.524). CRWV has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.029). P/S Ratio (6.892) is also within normal values, averaging (74.534).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CRWV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRWV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
Advertisement